DBDDiebold Nixdorf, Incorporated

$63.68+12% 1Y

Is the business good?

Good

A genuinely good business: 7 of 9 health tests passed, earnings fully cash-backed (1.6×), and margins widening.

3 good, 1 neutral
Fundamental health (F-score)7 / 9SEC EDGAR · Dec 31, 2025

High fundamental quality. Nine pass/fail tests of year-over-year health from the filings.

Profits arrive as cash1.55×derived · Jun 30, 2026

Operating profit is fully backed by cash. Conversion is worsening vs a year ago.

Margin direction, 3 years+9.3 pts

Positive operating leverage, operating profit is growing faster than sales, so margins widen as the business scales.

Where ROE comes from2% ROA

A balanced mix of margins, efficiency, and leverage. ROE 9% = margin × turnover × leverage.

Unless marked, from derived.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Leverage (Debt/EBITDA)middle of the market

Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.

How good a business is DBD?

Diebold Nixdorf, Incorporated earns 12% on the capital it employs against a 9.0% cost of capital, so the business is worth more the bigger it gets.

12%

Return on invested capital · cost of capital 9.0% · 2.7 points above what the capital costs: growth creates value

Operating margin
6.4%

Operating margin · Software - Application median 6.4% · 12 months to Q2 2026

Cash conversion
1.55×

Cash conversion · 1.65× a year ago · operating cash flow covers the operating profit after tax

Share count, year on year
−5.9%

Share count, year on year · bought back, each share owns more of the company

Operating margin by fiscal year
YearOperating margin
FY2019−0.60%
FY20200.62%
FY20213.5%
FY2022−6.1%
FY20244.9%
FY20256.4%
Details›
Gross margin12 months to Q2 2026
25%
Operating margin12 months to Q2 2026
6.4%
Net margin12 months to Q2 2026
2.9%
R&D as % of revenue
2.2%
Revenue, trailing twelve months
$3.87B
Net income, trailing twelve months
$111M
Return on invested capitaloperating profit after tax ÷ debt + equity − cash
12%

Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.